Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling - Report - MDSpire
Advertisement
Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling
Clinical Report: Wogonoside Reduces Inflammation and Cell Death in HCE-T Cells
Overview
Wogonoside (WGS) demonstrates protective effects against hyperosmotic stress in human corneal epithelial cells by enhancing cell viability and reducing inflammation through the PI3K/AKT signaling pathway. This suggests its potential as a therapeutic candidate for dry eye-related epithelial injury.
Background
Dry eye disease is a common ocular surface disorder that significantly impacts quality of life and can lead to severe complications. Hyperosmotic stress is a key factor in the pathogenesis of dry eye, promoting inflammation and apoptosis in corneal epithelial cells. Understanding the mechanisms by which compounds like WGS can mitigate these effects is crucial for developing effective treatments.
Data Highlights
Parameter
Effect of WGS
Cell Viability
Improved
Apoptosis
Reduced
IL-1β Levels
Decreased
IL-6 Levels
Decreased
MMP-9 Levels
Decreased
Key Findings
WGS improved cell viability and proliferation in hyperosmotic HCE-T cells.
WGS reduced levels of inflammatory mediators IL-1β, IL-6, and MMP-9.
The protective effects of WGS were associated with the restoration of PI3K/AKT signaling.
AKT1 was identified as a candidate target for WGS through network pharmacology and molecular docking.
Inhibition of AKT signaling with MK-2206 partially attenuated the protective effects of WGS.
Clinical Implications
The findings suggest that WGS may serve as a novel therapeutic agent for managing dry eye disease by targeting hyperosmotic stress-induced inflammation and apoptosis. Further research is warranted to validate these effects in vivo and explore the potential of WGS in clinical settings.
Conclusion
Wogonoside shows promise in alleviating hyperosmotic stress-related injury in corneal epithelial cells, primarily through the PI3K/AKT signaling pathway. This positions WGS as a potential candidate for further investigation in the treatment of dry eye disease.
